Samrat Pharmachem bulk deals and stake changes
BSE: 530125Pharmaceuticals & BiotechnologySmall Cap
Last close ₹277.50down ₹10.60 (3.68%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹288.10.
52-week range of traded prices to 23 Oct 2026
₹190.00Low, 30 Mar 2026₹309.85High, 30 Oct 2025
- Next results date: the board meets on 14 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹86 Cr3,210th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −2.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.16
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,601
Samrat Pharmachem stake sales and purchases
All 3 disclosures on record.
Nov 2021
- SoldMala Ranjit Bhavnani & Ranjit Bhavnani0.02% of the company500 sharesholds 4.99% after29 Nov 2021 · filed under the 2% rule · Market
- SoldMala Ranjit Bhavnani & Ranjit Hiranand Bhavnani0.02% of the company500 sharesholds 4.99% after29 Nov 2021 · filed under the 2% rule · Market
Apr 2014
- AcquiredMala R Bhavnani0.30% of the company10,637 sharesholds 5.20% after23 Apr 2014 · filed under the 5% rule · Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Samrat Pharmachem bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Monday 9 Sep 20241 firm · ₹0 bought · ₹0.68 Cr soldNet sold ₹0.68 Cr
- SoldGOLECHHA GLOBAL FINANCE LIMITEDSold 16,000 at ₹426.160.52% of the company₹0.68 Cr
Monday 7 Aug 20232 firms · ₹0.54 Cr bought · ₹1.29 Cr soldNet sold ₹0.75 Cr
- SoldALERT CONSULTANTS & CREDIT PRIVATE LIMITEDSold 21,769 at ₹345.740.70% of the company₹0.75 Cr
- Both waysSETU SECURITIES PVT. LTD.Bought 15,602 at ₹344.43Sold 15,602 at ₹341.650.50% of the companyNet nil₹0.54 Cr bought
Thursday 27 Jul 20231 firm · ₹0 bought · ₹0.96 Cr soldNet sold ₹0.96 Cr
- SoldGOLECHHA GLOBAL FINANCE LIMITEDSold 23,630 at ₹405.820.76% of the company₹0.96 Cr
Thursday 18 Aug 20221 firm · ₹1.38 Cr bought · ₹0 soldNet bought ₹1.38 Cr
- BoughtHARISHKUMARGUPTABought 22,000 at ₹629.200.71% of the company₹1.38 Cr
Monday 10 Jan 20221 firm · ₹0 bought · ₹1.29 Cr soldNet sold ₹1.29 Cr
- SoldMALA R BHAVNANISold 28,294 at ₹454.530.92% of the company₹1.29 Cr
Friday 7 Jan 20222 firms · ₹2.75 Cr bought · ₹3.15 Cr soldNet sold ₹0.41 Cr
- SoldMALA R BHAVNANISold 78,000 at ₹404.452.52% of the company₹3.15 Cr
- BoughtADVANI PRIVATE LIMITEDBought 68,000 at ₹404.222.20% of the company₹2.75 Cr
Thursday 23 Dec 20211 firm · ₹0.61 Cr bought · ₹0 soldNet bought ₹0.61 Cr
- BoughtTINA GOYALBought 18,800 at ₹322.520.61% of the company₹0.61 Cr
Monday 20 Dec 20211 firm · ₹0.43 Cr bought · ₹0 soldNet bought ₹0.43 Cr
- BoughtTINA GOYALBought 16,000 at ₹269.140.52% of the company₹0.43 Cr
Friday 8 Dec 20172 firms · ₹0.18 Cr bought · ₹0.16 Cr soldNet bought ₹0.01 Cr
- BoughtAASHIRWAD INVESTMENTSBought 21,441 at ₹81.950.69% of the company₹0.18 Cr
- SoldEUGENE NAPOLEON JACOBSold 20,000 at ₹82.000.65% of the company₹0.16 Cr
Friday 17 Feb 20171 firm · ₹0.28 Cr bought · ₹0 soldNet bought ₹0.28 Cr
- BoughtSHARAD KANAYALAL SHAHBought 41,570 at ₹68.421.35% of the company₹0.28 Cr
Monday 26 Sep 20162 firms · ₹0.07 Cr bought · ₹0.07 Cr soldNet nil
- BoughtPARIKSHIT K NOTARIABought 20,000 at ₹37.050.65% of the company₹0.07 Cr
- SoldPRAKASH PRAKASHSold 19,975 at ₹37.050.65% of the company₹0.07 Cr
Friday 20 Mar 20151 firm · ₹0.10 Cr bought · ₹0.10 Cr soldNet nil
- Both waysPRASANT KUMAR GUPTABought 21,542 at ₹45.77Sold 21,542 at ₹44.88Net nil₹0.10 Cr bought
Wednesday 18 Mar 20151 firm · ₹0 bought · ₹0.07 Cr soldNet sold ₹0.07 Cr
- SoldTAPAN MAHENDRA BHAVSARSold 16,900 at ₹38.55₹0.07 Cr
Monday 16 Mar 20151 firm · ₹0.06 Cr bought · ₹0.02 Cr soldNet bought ₹0.04 Cr
- Both waysHIRENSINH PRUTHVIRAJSINH BHATTIBought 23,299 at ₹26.92Sold 8,000 at ₹24.53Net +15,299 shares₹0.06 Cr bought
Friday 28 Mar 20141 firm · ₹0 bought · ₹0.03 Cr soldNet sold ₹0.03 Cr
- SoldSNEHA PRAKASH SHAHSold 15,720 at ₹18.61₹0.03 Cr
Thursday 27 Mar 20141 firm · ₹0.03 Cr bought · ₹0 soldNet bought ₹0.03 Cr
- BoughtSNEHA PRAKASH SHAHBought 15,720 at ₹20.79₹0.03 Cr
Monday 26 Mar 20121 firm · ₹0.05 Cr bought · ₹0 soldNet bought ₹0.05 Cr
- BoughtLAKE CITY TRADERS PRIVATE LIMITEDBought 15,499 at ₹34.75₹0.05 Cr
Friday 2 Sep 20111 firm · ₹0.05 Cr bought · ₹0.11 Cr soldNet sold ₹0.06 Cr
- Both waysBP FINTRADE PRIVATE LIMITEDBought 15,449 at ₹34.20Sold 33,114 at ₹34.04Net −17,665 shares₹0.05 Cr bought
Tuesday 21 Aug 20071 firm · ₹0.03 Cr bought · ₹0 soldNet bought ₹0.03 Cr
- BoughtVIJAY KUMAR REDDYBought 17,500 at ₹18.12₹0.03 Cr
Wednesday 18 Jul 20072 firms · ₹0.11 Cr bought · ₹0.08 Cr soldNet bought ₹0.03 Cr
- Both waysHITESH JHAVERIBought 56,135 at ₹13.76Sold 40,849 at ₹13.99Net +15,286 shares₹0.08 Cr bought
- Both waysM P VORA SHARES AND SECURITIES P LTDBought 20,842 at ₹13.64Sold 16,342 at ₹12.23Net +4,500 shares₹0.03 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 31 deals on record from 4 Jan 2004.